重症COVID-19肺炎康复早期肺纤维化的初步经验
该单中心回顾性研究分析了2020年1月12日至3月16日收治的12例重症COVID-19肺炎ICU患者,临床症状缓解或消失后收集临床资料并聚焦最近一次CT影像特征。患者平均年龄58.8±16.2岁,全部经历ARDS(9例中重度),6例使用无创通气、4例机械通气、1例ECMO。从发病到末次随访CT平均56.1±7.7天,CT显示磨玻璃影减少而纤维化逐渐增加,纤维条索(12/12,100%)、磨玻璃影(10/12,83.3%)、胸膜下线(10/12,83.3%)、牵拉性支气管扩张(10/12,83.3%)常见。结论认为纤维条索和磨玻璃影是重症COVID-19肺炎康复早期常见CT征象,应密切监测幸存者的肺纤维化征象。
要点
- 12例重症COVID-19肺炎ICU幸存者康复早期(发病至末次CT平均56.1±7.7天)CT显示磨玻璃影减少而纤维化逐渐增加。
- 纤维条索见于12/12(100%),磨玻璃影、胸膜下线、牵拉性支气管扩张各见于10/12(83.3%)。
- 8例(66.7%)以网状影和小叶间隔增厚为主,4例(33.3%)以磨玻璃影为主,累及肺段174/216(80.6%)。
- 全部患者经历ARDS(9例中重度),6例无创通气、4例机械通气、1例ECMO,淋巴细胞计数降至0.67±0.3(×10^9/L)。
- 重症COVID-19肺炎幸存者康复早期应密切监测肺纤维化征象。
适用人群与场景
- 2020年1月12日至3月16日单中心收治的12例SARS-CoV-2核酸阳性ICU患者,临床症状已缓解或消失。
- 全部患者经历ARDS,其中9例为中度至重度。
诊断标准与关键阈值
- SARS-CoV-2(COVID-19)核酸检测阳性。
- 全部患者符合急性呼吸窘迫综合征(ARDS),其中9例为中重度。
处置流程与药物剂量
- 6例患者使用无创呼吸机。
- 4例患者使用机械通气。
- 1例患者接受体外膜肺氧合(ECMO)治疗。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 单中心回顾性分析12例重症COVID-19肺炎ICU患者,平均年龄58.8±16.2岁,最常见症状为发热(100%)、呼吸困难(100%)和咳嗽(83.3%)。
- 从发病到末次随访CT平均56.1±7.7天,CT显示磨玻璃影(GGO)减少而纤维化逐渐增加。
- 常见CT特征:磨玻璃影10/12(83.3%)、胸膜下线10/12(83.3%)、纤维条索12/12(100%)、牵拉性支气管扩张10/12(83.3%)。
- 8例(66.7%)以网状影和小叶间隔增厚为主,4例(33.3%)以磨玻璃影为主,累及肺段174/216(80.6%)。
- 淋巴细胞计数降至0.67±0.3(×10^9/L)。
证据类型、等级与局限
- 单中心回顾性研究,样本量12例。
- 原文未述局限性。
对床旁实践的改变
- 对重症COVID-19肺炎ICU幸存者,在康复早期(发病后约56天)应关注CT上的纤维条索和磨玻璃影,并密切监测肺纤维化征象。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate chest computed tomography (CT) findings associated with severe COVID-19 pneumonia in the early recovery period.
METHODS: We retrospectively analyzed the cases of patients diagnosed with severe COVID-19 pneumonia at a single center between January 12, 2020, and March 16, 2020. The twelve ICU patients studied had been diagnosed SARS-CoV-2 (COVID-19) nucleic acid positive. Patient clinical symptoms were relieved or disappeared, and basic clinical information and laboratory test results were collected. The study focused on the most recent CT imaging characteristics.
RESULTS: The average age of the 12 patients was 58.8 ± 16.2 years. The most prevalent symptoms were fever (100%), dyspnea (100%), and cough (83.3%). All patients experienced acute respiratory distress syndrome (ARDS), of which 9 were moderate to severe. Six patients used noninvasive ventilators, and 4 patients used mechanical ventilation. One patient was treated with extracorporeal membrane oxygenation (ECMO). The lymphocyte count decreased to 0.67 ± 0.3 (× 10 9/L). The average day from illness onset to the last follow-up CT was 56.1 ± 7.7 d. The CT results showed a decrease in ground glass opacities (GGO), whereas fibrosis gradually increased. The common CT features included GGO (10/12, 83.3%), subpleural line (10/12, 83.3%), fibrous stripes (12/12, 100%), and traction bronchiectasis (10/12, 83.3%). Eight patients (66.7%) showed predominant reticulation and interlobular thickening. Four patients (33.3%) showed predominant GGO. Lung segments involved were 174/216 (80.6%).
CONCLUSIONS: Fibrous stripes and GGO are common CT signs in critically ill patients with COVID-19 pneumonia in the early recovery period. Signs of pulmonary fibrosis in survivors should be carefully monitored.
参考来源
- Fang Y, Zhou J, Ding X, et al. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am J Emerg Med. 2020. PMID: 33071084. doi:10.1016/j.ajem.2020.05.120
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。